|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
We wanted you to be aware that the FDA has granted accelerated approval of IBRANCE® (palbociclib) for the treatment of postmenopausal women with ER+/HER2- advanced breast cancer. Click here to see the press release!
We wanted you to be aware that FDA-approved Hysingla™ ER (hydrocodone bitartrate) extended-release tablets CII has commercially launched in the U.S.
Please click here to view the press release.
Click here for a CME/CEU activity on Improving Treatment of Atrial Fibrillation and Stoke
Otezla® (apremilast) is approved for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Please click here for more information.
Click here to view our Complimentary Online CME/CEU Webcasts
OAs part of APhA's longstanding and ongoing commitment to helping its members ensure optimal and safe patient use of prescription medications, nonprescription products, and dietary supplements, APhA convened national pharmacy and medicine leaders and other stakeholders on March 26.
Click here for more information
US introduces new DNA standard for ensuring accuracy of genetic tests
The New York Times
The federal government opened the door to a new era of genetic medicine by introducing a standard way to ensure the accuracy of DNA tests used to tailor treatments for individual patients.
Scientists have identified hundreds of genetic mutations that appear to increase the risk of diseases, including cancer, Alzheimer’s and cystic fibrosis. But laboratories often report different results when they analyze genes obtained from samples of the same blood or tissue, because of variations in their testing equipment and methods.
Early bird or night owl? It could be in your genes
There are two types of people in this world: those who do their best work first thing in the morning just after the sun drags itself out of bed, and those who can only operate at night when the people who host late-night TV infomercials for hair-in-a-can and miracle towels are telling their audience they really need to get some sleep.
Do mosquitoes love you? Maybe blame your genes
The Dallas Morning News
Your genes might affect whether mosquitoes prefer to snack on you or someone else, a new study shows.
In experiments with identical and fraternal twins, a team at the London School of Hygiene & Tropical Medicine discovered that genes influence whether a person’s body odor attracts or repels mosquitoes.
3 ways personalized medicine could completely transform your life
The Motley Fool
Depending on who you ask, opinions on the health and efficiency of the U.S. healthcare system vary wildly.
Ask consumers whether they have a favorable or unfavorable review of the new health reform law, Obamacare, and you'll get a decidedly negative tone.
BioFeedback for immunoglobulin is a health outcomes reporting program that provides clinical feedback on the use of immunoglobulin in autoimmune-related disorders. Physicians and medical directors can now deploy clinical interventions when they have the greatest impact on healthcare quality and costs.
Request more information or schedule a personal introduction.
'Vaccine on demand' approach to personal cancer treatment steps closer
Medical News Today
Researchers behind a new study say their findings bring us closer to realizing the promise of personalized immunotherapy — the ability to rapidly produce a vaccine that trains a patient's immune system to destroy tumors and leave healthy tissue intact.
Combination of stem cell and drug therapy could reverse Type 2 diabetes
Stem cell research is heralding a new age of possibl emedical treatments as scientists use them to grow transplantable cells and organs.
Now, it appears those new treatments might include one for Type 2 diabetes.
Unproven stem cell procedures flourish across the US, outpacing regulation
The Associated Press via U.S. News & World Report
The liquid is dark red, a mixture of fat and blood, and Dr. Mark Berman pumps it out of the patient's backside. He treats it with a chemical, runs it through a processor — and injects it into the woman's aching knees and elbows.
The "soup," he says, is rich in shape-shifting stem cells — magic bullets that, according to some doctors, can be used to treat everything from Parkinson's disease to asthma to this patient's chronic osteoarthritis.
EMERGING MEDICAL TECHNOLOGIES
'Flurry' of new tech on tap for care coordination
Healthcare IT News
The market for technology aimed at closing gaps in patient care is set for big growth in the next five years, as vendors aim to "smooth the pain points associated with transitioning from fee-for-service." As the shift to value-based care necessitates the ability to manage patients across acute, ambulatory and home care settings, electronic health records are not enough, according to the report.
Ranked #1 in the Nation for Quality of Care.
Our Meaningful Use certified software is designed by medical providers, making SOAPware the preferred EHR for medical professionals!
To find out how to feature your company in the GBEMTI eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
Is the wearable health movement sustainable?
One of the hottest areas of wearables is fitness monitors from Fitbit, Misfit, Jawbone, Garmin, etc. In 2014, approximately 90 million were sold and the interest in using some type of wearable to monitor health continues to be strong.
ACCOUNTABLE CARE ORGANIZATIONS
To succeed long-term, ACOs must increase consumer focus
The accountable care organization model has seen substantial progress in recent years, but to succeed in the long term, the Next Generation ACO model must provide comprehensive data and engage with consumers, 12 consumer advocacy groups said in a letter to the Centers for Medicare & Medicaid Services.
FDA: NEW TREATMENTS AND TECHNOLOGY
Can FDA reclassify generic drugs?
The Wall Street Journal
To what extent should the Food and Drug Administration be allowed to reclassify a generic drug when the agency believes it is no longer equivalent to the brand-name version?
The issue is being raised in an unusual lawsuit claiming the agency overstepped its bounds by deciding two generic drugs used to treat attention deficit hyperactivity disorder should no longer be substituted for the widely used Concerta treatment.
The outcome of the case may have implications for generic drug makers and the FDA.
Cystic fibrosis drug wins approval of FDA advisory panel
The New York Times
A federal advisory committee recently recommended approval of a drug from Vertex Pharmaceuticals that might eventually help nearly half of patients with cystic fibrosis.
The advisory committee to the Food and Drug Administration voted 12 to 1 that the drug, which Vertex plans to call Orkambi, was safe and effective enough to be approved. The F.D.A. is supposed to decide by July 5.
How much money is spent on healthcare and disease eradication around
With our global population growing larger year after year, more treatments for illnesses and sickness are necessary, and it's not cheap.
The infographic below explores the amount spent (and projected to be spent) on healthcare from five first-world nations and what exactly it's being spent on.
Healthcare executives to CMS: Stop micromanaging quality
Medicare would work a lot better if the Centers for Medicare and Medicaid Services would stop micromanaging quality measurement, a healthcare executive said recently.
"I would love for the administration to recognize that they need to stay 'high-level,'" Dr. Richard Gilfillan, president and CEO of Trinity Health, a Livonia, Michigan-based healthcare network serving patients in 21 states, said at a briefing on the future of Medicare sponsored by the Alliance for Health Reform. "Thirty-two quality metrics for accountable care organizations to meet is too much — we should have five to seven patient-reported functional status outcomes."
Missed last week's issue? See which articles your colleagues read most.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063